Filing Details
- Accession Number:
- 0001209191-21-053523
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-26 17:54:36
- Reporting Period:
- 2021-08-25
- Accepted Time:
- 2021-08-26 17:54:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1637715 | Reneo Pharmaceuticals Inc. | RPHM | Pharmaceutical Preparations (2834) | 472309515 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1855115 | R. Vineet Jindal | C/O Reneo Pharmaceuticals, Inc. 18575 Jamboree Road, Suite 275-S Irvine CA 92612 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-08-25 | 5,000 | $7.44 | 5,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The weighted average purchase price for the transaction was $7.4353. The shares were purchased at a range of prices between $7.39 and $7.47. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
Billionaire Hedge Funds
